Australia's largest stock trading and investment forum Australia's #1 stock forum

CPH

0.00%

0.9¢ creso pharma limited

Ann: Mernova on track for quarter-on-quarter revenue growth, page-27

First 27 Last

Share
Profile

Follow
edwardc

688 Posts.

132

08/12/21

15:43

Post #: 58163806
Share

Originally posted by surfthemarket: ↑

The bashers are focusing on costs because a healthy increase in revenue doesn't suit their narrative.

As I pointed out, with some calculated analysis, after the last Quarterly Report - large corporate costs were down 45% from the previous quarter, cost savings on manufacturing & operations down 7.5% and staff costs constant. In business, staff costs grow in line with company expansion - so make a note of that experts ............. keep up eddie.

As a comparison, I heard a podcast yesterday that looked at the Top 5 small caps of 2021. Their costs went like this ;
Sayona - SP up 1447% - CY Loss $4.38 million
Red Hill Iron - SP up 1189% - CY Loss $2.65 million
Provence Resources - SP up 971% - CY Loss $14.5 million
Arizona Lithium - SP up 933% - CY Loss $2.9million
Lake Resources - SP up 887% - CY Loss $3.46 million

Reigning in costs and increasing revenue is what it's all about for a start-up to be successful. The fundamentals of Creso are still good - except for .......... (I'll address that later for you Sadaji)

Expand

except you analysed the last quarter..

i have been looking at their financials for 3 years.. (paints you a better picture) which is why I arrived at my conclusion why this management have to go and called them out multiple times..

I have eaten my fair share of humble pie...Would you like some reality pie?

Last edited by edwardc: 08/12/21

CPH Price at posting: 9.1¢ Sentiment: Sell Disclosure: Not Held
1 Upvote

1 Great analysis

Reply

Top Stories

ASL

Andean discovers up to 4,649 AgEq through maiden drilling in Chile

SKC

SkyCity to lose NZ$5M in 2025 over complaint closedown

M2R

Miramar sniffs 5.48% Cu, 54.4% Pb and 73.48g/t Ag at new WA prospect

WGX

Australian foreign investment regulators greenlight Westgold's buyout of Karora

AI stocks: What to expect in 2024-25